Tokyo University [clinicaltrials_resource:ed2cbd0215110cb0e80bb0350a455abe]
Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Takashi Kadowaki, Professor [clinicaltrials_resource:28b487e4e23b6eb227b950a8e0d9b6bc]Hiroyuki Isayama, MD [clinicaltrials_resource:2a896c3a9f9ce0529047b74a846349f6]Toshiaki Watanabe, M.D. [clinicaltrials_resource:36f8d196475468add27873a1309eb721]Sumito Ogawa, MD. PhD. [clinicaltrials_resource:58bf2b8197fae1d65baf6821f134518c]Hiroyuki Isayama, MD [clinicaltrials_resource:6dfa612d9acc19a4a51c53aab3b2842c]Hiroyuki Isayama, MD [clinicaltrials_resource:ca7ee5d7d1f1656a94e2811593d5ed61]Hiroyuki Isayama, MD [clinicaltrials_resource:defc229011ec2746909396844b84484b]
affiliation [clinicaltrials_vocabulary:affiliation]
clinicaltrials:NCT00673777clinicaltrials:NCT00674258clinicaltrials:NCT00677287clinicaltrials:NCT00677326clinicaltrials:NCT00677612clinicaltrials:NCT00678509Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681252]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681330]Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681421]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681577]clinicaltrials:NCT00683085clinicaltrials:NCT00683358clinicaltrials:NCT02410369
collaborator [clinicaltrials_vocabulary:collaborator]
Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) [clinicaltrials:NCT00301392]Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine [clinicaltrials:NCT00509470]clinicaltrials:NCT00673777clinicaltrials:NCT00674258clinicaltrials:NCT00677287clinicaltrials:NCT00677326clinicaltrials:NCT00677612clinicaltrials:NCT00678509Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681252]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681330]Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681421]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681577]clinicaltrials:NCT00683085clinicaltrials:NCT00683358Optimal Treatment for Spinal Cord Injury Associated With Cervical Canal Stenosis (OSCIS) Study [clinicaltrials:NCT01485458]Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes [clinicaltrials:NCT02136589]Biliary Drainage in Patients With Duodenal Metal Stent [clinicaltrials:NCT02376907]clinicaltrials:NCT02410369Comparison of Outcomes Between Parenteral and Enteral Nutrition [clinicaltrials:NCT02512224]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) [clinicaltrials:NCT00301392]Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine [clinicaltrials:NCT00509470]clinicaltrials:NCT00673777clinicaltrials:NCT00674258clinicaltrials:NCT00677287clinicaltrials:NCT00677326clinicaltrials:NCT00677612clinicaltrials:NCT00678509Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681252]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681330]Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer [clinicaltrials:NCT00681421]Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [clinicaltrials:NCT00681577]clinicaltrials:NCT00683085clinicaltrials:NCT00683358Optimal Treatment for Spinal Cord Injury Associated With Cervical Canal Stenosis (OSCIS) Study [clinicaltrials:NCT01485458]Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes [clinicaltrials:NCT02136589]Biliary Drainage in Patients With Duodenal Metal Stent [clinicaltrials:NCT02376907]clinicaltrials:NCT02410369Comparison of Outcomes Between Parenteral and Enteral Nutrition [clinicaltrials:NCT02512224]
source [clinicaltrials_vocabulary:source]
Tokyo University [clinicaltrials_resource:ed2cbd0215110cb0e80bb0350a455abe]
Bio2RDF identifier
ed2cbd0215110cb0e80bb0350a455abe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ed2cbd0215110cb0e80bb0350a455abe
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:ed2cbd0215110cb0e80bb0350a455abe
title
Tokyo University
@en
type
label
Tokyo University [clinicaltrials_resource:ed2cbd0215110cb0e80bb0350a455abe]
@en